F.D.A

The Food and Drug Administration said on Friday that it would permit some patients with deadly pancreatic cancer to receive early access to a promising, highly coveted drug. The treatment, daraxonrasib, taken as three pills a day, is not yet approved for use. But many patients have been desperate to try it. The drug recently…